Vimarsana
Biggest News Aggregation in the World

Page 2 - Nasdaq Tern News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Tern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Tern Today - Breaking & Trending Today

Brokerages Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Price Target at $14.64 - Vimarsana News

Brokerages Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Price Target at $14.64

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The […]

Terns Pharmaceuticals (NASDAQ:TERN) vs. Sernova (OTCMKTS:SEOVF) Head-To-Head Comparison - Vimarsana News

Terns Pharmaceuticals (NASDAQ:TERN) vs. Sernova (OTCMKTS:SEOVF) Head-To-Head Comparison

Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) and Sernova (OTCMKTS:SEOVF – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations and profitability. Profitability This table compares Terns Pharmaceuticals and Sernova’s […]

Source: wkrb13.com
Suvretta Capital Management LLC Acquires 2,113,560 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Vimarsana News

Suvretta Capital Management LLC Acquires 2,113,560 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN)

Suvretta Capital Management LLC increased its holdings in shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 61.3% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 5,561,835 shares of the company’s stock after purchasing an additional 2,113,560 shares during the period. Terns Pharmaceuticals makes up approximately […]

Terns Pharmaceuticals (NASDAQ:TERN) Rating Reiterated by JMP Securities - Vimarsana News

Terns Pharmaceuticals (NASDAQ:TERN) Rating Reiterated by JMP Securities

JMP Securities reissued their market outperform rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a $17.00 price objective on the stock. Several other research analysts have also recently issued reports on TERN. HC Wainwright decreased their price objective on […]

Source: wkrb13.com
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Rating of "Moderate Buy" from Brokerages - Vimarsana News

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Rating of "Moderate Buy" from Brokerages

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 […]